VOYA Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,975
| Closed | -$97.2K | – | 2755 |
|
|
2024
Q4 | $97.2K | Sell |
31,975
-2,183
| -6% | -$9.51K | ﹤0.01% | 2583 |
|
|
2024
Q3 | $177K | Sell |
34,158
-1,226
| -3% | -$6.09K | ﹤0.01% | 2520 |
|
|
2024
Q2 | $90.9K | Buy |
35,384
+6,618
| +23% | +$22.6K | ﹤0.01% | 2690 |
|
|
2024
Q1 | $142K | Sell |
28,766
-5,435
| -16% | -$32.2K | ﹤0.01% | 2548 |
|
|
2023
Q4 | $301K | Buy |
34,201
+683
| +2% | +$5.6K | ﹤0.01% | 2346 |
|
|
2023
Q3 | $384K | Buy |
33,518
+393
| +1% | +$7.56K | ﹤0.01% | 2184 |
|
|
2023
Q2 | $838K | Buy |
33,125
+2,603
| +9% | +$81.1K | ﹤0.01% | 1774 |
|
|
2023
Q1 | $983K | Hold |
30,522
| – | – | ﹤0.01% | 1666 |
|
|
2022
Q4 | $563K | Buy |
30,522
+2,775
| +10% | +$63.5K | ﹤0.01% | 1969 |
|
|
2022
Q3 | $749K | Buy |
27,747
+593
| +2% | +$12K | ﹤0.01% | 1786 |
|
|
2022
Q2 | $375K | Sell |
27,154
-591
| -2% | -$9.1K | ﹤0.01% | 2018 |
|
|
2022
Q1 | $541K | Hold |
27,745
| – | – | ﹤0.01% | 1863 |
|
|
2021
Q4 | $453K | Buy |
27,745
+327
| +1% | +$5.45K | ﹤0.01% | 2082 |
|
|
2021
Q3 | $764K | Hold |
27,418
| – | – | ﹤0.01% | 1773 |
|
|
2021
Q2 | $813K | Sell |
27,418
-271
| -1% | -$7.82K | ﹤0.01% | 1793 |
|
|
2021
Q1 | $774K | Buy |
27,689
+60
| +0.2% | +$1.66K | ﹤0.01% | 1754 |
|
|
2020
Q4 | $783K | Buy |
27,629
+6,619
| +32% | +$171K | ﹤0.01% | 1645 |
|
|
2020
Q3 | $528K | Buy |
21,010
+946
| +5% | +$24.8K | ﹤0.01% | 1645 |
|
|
2020
Q2 | $490K | Sell |
20,064
-5,027
| -20% | -$99.2K | ﹤0.01% | 1681 |
|
|
2020
Q1 | $371K | Buy |
25,091
+3,253
| +15% | +$67.3K | ﹤0.01% | 1807 |
|
|
2019
Q4 | $354K | Buy |
21,838
+5,330
| +32% | +$82.7K | ﹤0.01% | 2088 |
|
|
2019
Q3 | $215K | Buy |
16,508
+733
| +5% | +$8.97K | ﹤0.01% | 2218 |
|
|
2019
Q2 | $205K | Buy |
15,775
+2,169
| +16% | +$27.3K | ﹤0.01% | 2298 |
|
|
2019
Q1 | $214K | Hold |
13,606
| – | – | ﹤0.01% | 2241 |
|
|
2018
Q4 | $274K | Buy |
13,606
+1,173
| +9% | +$25.8K | ﹤0.01% | 2077 |
|
|
2018
Q3 | $309K | Hold |
12,433
| – | – | ﹤0.01% | 2132 |
|
|
2018
Q2 | $341K | Buy |
12,433
+2,041
| +20% | +$61.3K | ﹤0.01% | 2072 |
|
|
2018
Q1 | $320K | Hold |
10,392
| – | – | ﹤0.01% | 2069 |
|
|
2017
Q4 | $372K | Hold |
10,392
| – | – | ﹤0.01% | 2019 |
|
|
2017
Q3 | $286K | Hold |
10,392
| – | – | ﹤0.01% | 2190 |
|
|
2017
Q2 | $274K | Buy |
+10,392
| New | +$232K | ﹤0.01% | 2221 |
|
|
2016
Q1 | – | Sell |
-5,920
| Closed | -$202K | – | 2530 |
|
|
2015
Q4 | $202K | Buy |
+5,920
| New | +$205K | ﹤0.01% | 2271 |
|
|
2015
Q3 | – | Sell |
-7,579
| Closed | -$242K | – | 2607 |
|
|
2015
Q2 | $242K | Buy |
+7,579
| New | +$195K | ﹤0.01% | 2395 |
|
Other funds holding RVNC
VOYA Investment Management's RVNC Position: Q1 2025 in Review
VOYA Investment Management sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 31,975 shares — an estimated $97.2K sold.
VOYA Investment Management first reported a position in RVNC in Q2 2015 and held it in 33 quarters. The position peaked at $983K in Q1 2023. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- VOYA Investment Management reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- VOYA Investment Management sold 31,975 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $97.2K.
- VOYA Investment Management first reported a position in Revance Therapeutics, Inc. in Q2 2015 and held it in 33 quarters.
- VOYA Investment Management's Revance Therapeutics, Inc. position peaked at $983K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on VOYA Investment Management's 13F filing for Q1 2025, filed 15 May 2025.